Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qualia NAD⁺ version 2
- Development stage
- Preclinical
- Lead developer
- Qualia Life Sciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Qualia NAD⁺ version 2 is a multi-ingredient dietary supplement developed by Neurohacker Collective, designed to increase intracellular levels of nicotinamide adenine dinucleotide (NAD⁺). As an updated formulation of the original Qualia NAD⁺, it aims to support cellular energy metabolism, DNA repair, and overall healthy aging. The product is currently being studied in a randomized, double-blind, placebo-controlled clinical trial (NCT07132801) involving healthy adults aged 35-75 to assess its impact on intracellular NAD⁺ levels and aging-related symptoms, such as fatigue and quality of life, compared to the first-generation formulation and a placebo. The study utilizes remote assessments and at-home finger-stick blood collection to evaluate efficacy and safety over a 28-day period.
- Brand names
- Qualia NAD⁺ version 2
- Other names
- Qualia NAD+ version 2Qualia NAD+ v2
02
Targets
NAD (Nicotinamide adenine dinucleotide)
Beyond the preview
Go deeper on Qualia NAD⁺ version 2.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qualia NAD⁺ version 2.